Asia Oceania Journal of Nuclear Medicine and Biology

Asia Oceania Journal of Nuclear Medicine and Biology

Limitations of 18F-FDG PET/CT in detecting direct bronchial metastasis from esophageal squamous cell carcinoma: A case report

Document Type : Case report

Authors
1 Department of Nuclear Medicine, 108 Military Central Hospital, Hanoi, Vietnam
2 Faculty of Nuclear Medicine, Hanoi Medical University, Hanoi, Vietnam
3 Department of Histo-pathology, 108 Military Central Hospital, Hanoi, Vietnam
4 Department of Radiation Oncology and Radiosurgery, 108 Military Central Hospital, Hanoi, Vietnam
5 Cancer Institute, 108 Military Central Hospital, Hanoi, Vietnam
6 Service of Nuclear Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
7 Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Korea
Abstract
Esophageal cancers predominantly metastasize through direct invasion, lymphatic dissemination, or hematogenous spread. Frequent metastatic locations comprise the liver, lymph nodes, lungs, and bones. However, direct bronchial metastases are extremely rare. We report a case of a 50-year-old male diagnosed with esophageal squamous cell carcinoma who received neoadjuvant chemoradiotherapy and subsequent esophagectomy with gastric pull-up reconstruction. Two years after surgery, follow-up imaging indicated suspicious bronchial lesion. On 18F-FDG PET/CT, the bronchial lesion exhibited only mild 18F-FDG uptake, which may underestimate its malignancy. Histopathological assessment verified metastatic squamous cell carcinoma, congruent with the primary esophageal tumor. This case illustrates the diagnostic limitations of 18F-FDG PET/CT in specific situations and emphasizes the necessity of incorporating clinical, endoscopic, and pathological findings in intricate cases.
Keywords
Subjects

1.    Oesophagus Fact Sheet. Global Cancer Observatory (GLOBOCAN 2022), International Agency for Research on Cancer (IARC).
2.    Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L. Sites of metastasis and overall survival in esophageal cancer: a population-based study. Cancer Management and Research. 2017; 9: 781–788.
3.    Madariaga ML, Gaissert HA. Secondary tracheal tumors: a systematic review. Annals of Cardiothoracic Surgery. 2018; 7(2):183. 
4.    Neeraj Gupta. Endobronchial metastasis: The challenge continues. Lung India. 2019; 36(3): 181-182. 
5.    Goense L, Van Rossum PS, Reitsma JB, Lam MG, Meijer GJ, Van Vulpen M, et al. Diagnostic performance of 18F-FDG PET and PET/CT for the detection of recurrent esophageal cancer after treatment with curative intent: a systematic review and meta-analysis. Journal of Nuclear Medicine. 2015; 56(7): 995-1002. 
6.    Gresham E, Parsa FD. Iatrogenic implantation of cancer cells during surgery. Hawai'i Journal of Health & Social Welfare. 2020; 79(1):4. 
7.    Kosugi SI, Kanda T, Nishimaki T, Nakagawa S, Yajima K, Ohashi M, et al. Successful treatment for esophageal carcinoma with lung metastasis by induction chemotherapy followed by salvage esophagectomy: Report of a case. World Journal of Gastroenterology. 2006; 12(25): 4101. 
8.    Liu D, Lu M, Li J, Yang Z, Feng Q, Zhou M, et al. The patterns and timing of recurrence after curative resection for gastric cancer in China. World Journal of Surgical Oncology. 2016; 14(1): 305. 
9.    Takashima S, Okubo S, Ota M. An Iatrogenic Metastasis. The American Journal of Medicine. 2015; 128(9): e15-6. 
10.Ayaz S. The Situations Which May Cause False-Negative Results in Oncological FDG-PET/CT Practice. The Ulutas Medical Journal. 2017; 3(1): 23-4. 
11.Connolly JL, Schnitt SJ, Wang HH, Longtine JA, Dvorak A, Dvorak HF. Role of the Surgical Pathologist in the Diagnosis and Management of the Cancer Patient. In: Kufe DW, Pollock RE, Weichselbaum RR, et al, editors. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; 2003.